We are live on
!
Find out more
LOM
Loeb Offshore Management Portfolio holdings
AUM
$547M
1-Year Est. Return
50.11%
This Fund
S&P 500
This Quarter
Est. Return
+16.42%
1 Year Est. Return
+50.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$128M
(+66%)
Cap. Flow
+$142M
Cap. Flow
% of AUM
43.72%
Top 10 Holdings %
Top 10 Hldgs %
19.35%
Holding
287
New
144
Increased
61
Reduced
24
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$7.8M |
| 2 |
Vodafone
VOD
|
+$5.41M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$5.35M |
| 4 |
PVD
Admin Fondos Pensions
PVD
|
+$5.29M |
| 5 |
SKS
SAKS INCORPORATED
SKS
|
+$4.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTB
Cooper Tire & Rubber Co.
CTB
|
+$7.13M |
| 2 |
VIAB
Viacom Inc. Class B
VIAB
|
+$6.94M |
| 3 |
AGN
Allergan plc
AGN
|
+$5.82M |
| 4 |
BMC
BMC SOFTWARE, INC
BMC
|
+$5.64M |
| 5 |
SFD
SMITHFIELD FOODS,INC
SFD
|
+$5.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.59% |
| 2 | Technology | 10.88% |
| 3 | Healthcare | 10.66% |
| 4 | Communication Services | 8.91% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
151
DELISTED
Celgene Corp
CELG
| $369K | 0.11% |
+4,786
| New | +$335K |
|
152
Sarepta Therapeutics
SRPT
$1.63B
| $359K | 0.11% |
+7,598
| New | +$293K |
|
|
ANLY
153
DELISTED
ANALYSTS INTL CORP COM STK (MN)
ANLY
| $354K | 0.11% |
+55,000
| New | +$268K |
|
154
Terex
TEX
$7.84B
| $346K | 0.11% |
+10,283
| New | +$312K |
|
155
MBIA
MBI
$278M
| $335K | 0.1% |
+32,767
| New | +$412K |
|
156
Pfizer
PFE
$144B
| $328K | 0.1% |
12,034
-15,370
| -56% | -$418K |
|
157
Cardinal Health
CAH
$54.5B
| $327K | 0.1% |
6,269
+1,369
| +28% | +$69.5K |
|
158
Amgen
AMGN
$212B
| $323K | 0.1% |
2,883
-117
| -4% | -$12.7K |
|
|
PRTK
159
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $321K | 0.1% |
+8,417
| New | +$301K |
|
|
WNR
160
DELISTED
Western Refining Inc
WNR
| $300K | 0.09% |
+10,000
| New | +$294K |
|
161
Zimmer Biomet
ZBH
$18.5B
| $292K | 0.09% |
+3,660
| New | +$288K |
|
|
AGN
162
DELISTED
Allergan Inc
AGN
| $289K | 0.09% |
+3,192
| New | +$287K |
|
163
Vertex Pharmaceuticals
VRTX
$124B
| $279K | 0.09% |
+3,683
| New | +$293K |
|
|
PCYC
164
DELISTED
PHARMACYCLICS INC
PCYC
| $273K | 0.08% |
1,974
-1,276
| -39% | -$142K |
|
|
MDVN
165
DELISTED
MEDIVATION, INC.
MDVN
| $272K | 0.08% |
9,078
-138,572
| -94% | -$3.96M |
|
166
Biogen
BIIB
$30.4B
| $271K | 0.08% |
1,125
+125
| +13% | +$28K |
|
167
Brookdale Senior Living
BKD
$3.67B
| $271K | 0.08% |
+10,296
| New | +$282K |
|
|
ISS
168
DELISTED
ISOFTSTONE HLDGS LTD ADS EACH REPSTG 10 ORD SHS (CYM)
ISS
| $270K | 0.08% |
54,910
+24,910
| +83% | +$128K |
|
169
Viatris
VTRS
$20.8B
| $269K | 0.08% |
+7,050
| New | +$248K |
|
170
Regeneron Pharmaceuticals
REGN
$72.9B
| $264K | 0.08% |
+845
| New | +$222K |
|
|
TRIB
171
Trinity Biotech
TRIB
$8.4M
| $264K | 0.08% |
+81
| New | +$237K |
|
|
GRFS
172
Grifois
GRFS
$5.44B
| $257K | 0.08% |
+17,000
| New | +$264K |
|
173
Eli Lilly
LLY
$1.09T
| $255K | 0.08% |
+5,075
| New | +$266K |
|
|
SNTS
174
DELISTED
SANTARUS INC
SNTS
| $253K | 0.08% |
+11,198
| New | +$266K |
|
175
Jazz Pharmaceuticals
JAZZ
$16.1B
| $246K | 0.08% |
+2,673
| New | +$216K |
|
Similar funds
RNS
ABI
AGCJ
ACM
NTP
MMC
CAMI
NES
Loeb Offshore Management's Q3 2013 Portfolio in Review
As of Q3 2013, Loeb Offshore Management held 287 positions worth $324M, up 66% from $196M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Loeb Offshore Management deployed $142M of net new capital in Q3 2013, opening 144 new positions and adding to 61 existing holdings. Its largest new stake was Vodafone: 170,988 shares worth $6.13M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 6.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Viacom Inc. Class B, an estimated $6.94M trimmed.
- Loeb Offshore Management's largest Q3 2013 buy was Vodafone: 170,988 shares worth $6.13M.
- Loeb Offshore Management added most to MetLife in Q3 2013, an estimated $7.8M increase.
- Loeb Offshore Management's biggest Q3 2013 reduction was Viacom Inc. Class B, cutting an estimated $6.94M.
- Loeb Offshore Management fully exited Cooper Tire & Rubber Co. in Q3 2013, selling an estimated $7.13M.
- Loeb Offshore Management's ten largest holdings make up 19% of its $324M portfolio in Q3 2013.
- Loeb Offshore Management opened 144 new positions and closed 54 in Q3 2013.
- Loeb Offshore Management's portfolio value rose 66% quarter-over-quarter to $324M.
Based on Loeb Offshore Management's 13F filing for Q3 2013, filed 14 Nov 2013.